X @The Wall Street Journal

Lilly(US:LLY) The Wall Street Journal·2026-03-21 22:15

Eli Lilly’s experimental drug retatrutide met trial endpoints, showing significant weight loss and blood sugar reductions. https://t.co/t4a97OCbBI ...